<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39408010</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>19</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>07</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Impact of COVID-19 on Psychiatric Patients: The Role of Vaccination, Comorbidities, and Biomarkers in Clinical Outcomes.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">5950</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm13195950</ELocationID><Abstract><AbstractText><b>Background/Objectives</b>: The COVID-19 pandemic has posed significant challenges, particularly for individuals residing in psychiatric facilities. This study aims to investigate the impact of COVID-19 on psychiatric patients, focusing on factors such as their vaccination status, comorbidities, medication regimens, and biomarkers like C-reactive protein (CRP) and ferritin. <b>Methods</b>: This retrospective study analyzed 100 patients with confirmed SARS-CoV-2 infections admitted to the private psychiatric clinic "Asclepius of Upper Volos" from March 2020 to March 2023. The data collected included sociodemographic characteristics, vaccination status, symptom severity, medication regimens, and levels of CRP and ferritin. Statistical analyses using IBM SPSS Statistics version 29 included Pearson's chi-square tests, Student's t-tests, and a survival time analysis via the log-rank test to assess associations between clinical characteristics and outcomes. <b>Results</b>: Among the participants, 64% were female and 74% received two doses of the COVID-19 vaccine. The majority experienced mild symptoms, with a survival rate of 74%. Statistically significant findings include a higher survival rate among vaccinated individuals (98.6%) versus unvaccinated individuals (1.4%, <i>p</i> &lt; 0.001). Comorbidities like chronic obstructive pulmonary disease (COPD), coronary artery disease, and renal failure were associated with severe symptoms and higher mortality rates. Higher ferritin levels were significantly associated with poorer outcomes, with survivors having a mean ferritin level of 246.2 (SD = 150.3) compared to the 416.9 (SD = 215.9) seen in non-survivors (<i>p</i> &lt; 0.001). Similarly, mean CRP levels were lower in survivors (1.58, SD = 1.96) than in non-survivors (3.46, SD = 2.92), with a <i>p</i>-value of 0.002. <b>Conclusions</b>: The findings underscore the importance of tailored health protocols and continued support for this vulnerable population. Enhanced strategies for managing comorbidities and utilizing biomarkers can aid in better predicting and improving psychiatric patient outcomes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Argyropoulos</LastName><ForeName>Konstantinos</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Public Health, School of Medicine, University of Patras, 26504 Patras, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Social Sciences, Hellenic Open University, 26335 Patras, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Argyropoulou-Grizanou</LastName><ForeName>Aikaterini-Aggeliki</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Social Sciences, Hellenic Open University, 26335 Patras, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jelastopulu</LastName><ForeName>Eleni</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-7499-4034</Identifier><AffiliationInfo><Affiliation>Department of Public Health, School of Medicine, University of Patras, 26504 Patras, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">CRP</Keyword><Keyword MajorTopicYN="N">biomarkers</Keyword><Keyword MajorTopicYN="N">ferritin</Keyword><Keyword MajorTopicYN="N">psychiatric patients</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>1</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39408010</ArticleId><ArticleId IdType="pmc">PMC11477535</ArticleId><ArticleId IdType="doi">10.3390/jcm13195950</ArticleId><ArticleId IdType="pii">jcm13195950</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization  WHO Coronavirus (COVID-19) Dashboard. 2022.  [(accessed on 15 September 2024)].  Available online:  https://covid19.who.int/</Citation></Reference><Reference><Citation>Riou J., Althaus C.L. Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020. Eurosurveillance. 2020;25:2000058. doi: 10.2807/1560-7917.ES.2020.25.4.2000058.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2020.25.4.2000058</ArticleId><ArticleId IdType="pmc">PMC7001239</ArticleId><ArticleId IdType="pubmed">32019669</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang Y.-T., Yang Y., Li W., Zhang L., Zhang Q., Cheung T., Ng C.H. Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed. Lancet Psychiatry. 2020;7:228–229. doi: 10.1016/S2215-0366(20)30046-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30046-8</ArticleId><ArticleId IdType="pmc">PMC7128153</ArticleId><ArticleId IdType="pubmed">32032543</ArticleId></ArticleIdList></Reference><Reference><Citation>Druss B.G. Addressing the COVID-19 Pandemic in Populations with Serious Mental Illness. JAMA Psychiatry. 2020;77:891–892. doi: 10.1001/jamapsychiatry.2020.0894.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2020.0894</ArticleId><ArticleId IdType="pubmed">32242888</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozloff N., Mulsant B.H., Stergiopoulos V., Voineskos A.N. The COVID-19 Global Pandemic: Implications for People With Schizophrenia and Related Disorders. Schizophr. Bull. 2020;46:752–757. doi: 10.1093/schbul/sbaa051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/schbul/sbaa051</ArticleId><ArticleId IdType="pmc">PMC7197583</ArticleId><ArticleId IdType="pubmed">32343342</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostuzzi G., Papola D., Gastaldon C., Schoretsanitis G., Bertolini F., Amaddeo F., Cuomo A., Emsley R., Fagiolini A., Imperadore G., et al. Safety of psychotropic medications in people with COVID-19: Evidence review and practical recommendations. BMC Med. 2020;18:215. doi: 10.1186/s12916-020-01685-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-020-01685-9</ArticleId><ArticleId IdType="pmc">PMC7360478</ArticleId><ArticleId IdType="pubmed">32664944</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatt S., Dhar A.K., Samanta M.K., Suttee A. Effects of Current Psychotropic Drugs on Inflammation and Immune System. Adv Exp Med Biol. 2023;1411:407–434. doi: 10.1007/978-981-19-7376-5_18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-981-19-7376-5_18</ArticleId><ArticleId IdType="pubmed">36949320</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunningham C., Dixon L.B. Health Disparities Among People With Serious Mental Illness. Psychiatr. Serv. 2020;71:412–413. doi: 10.1176/appi.ps.71406.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ps.71406</ArticleId><ArticleId IdType="pubmed">32233770</ArticleId></ArticleIdList></Reference><Reference><Citation>Cullen W., Gulati G., Kelly B.D. Mental health in the COVID-19 pandemic. QJM. 2020;113:311–312. doi: 10.1093/qjmed/hcaa110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcaa110</ArticleId><ArticleId IdType="pmc">PMC7184387</ArticleId><ArticleId IdType="pubmed">32227218</ArticleId></ArticleIdList></Reference><Reference><Citation>De Picker L.J., Dias M.C., Benros M.E., Vai B., Branchi I., Benedetti F., Borsini A., Leza J.C., Kärkkäinen H., Männikkö M., et al. Severe mental illness and European COVID-19 vaccination strategies. Lancet Psychiatry. 2021;8:356–359. doi: 10.1016/S2215-0366(21)00046-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00046-8</ArticleId><ArticleId IdType="pmc">PMC7906735</ArticleId><ArticleId IdType="pubmed">33609450</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazereel V., Van Assche K., Detraux J., De Hert M. COVID-19 vaccination for people with severe mental illness: Why, what, and how? Lancet Psychiatry. 2021;8:444–450. doi: 10.1016/S2215-0366(20)30564-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30564-2</ArticleId><ArticleId IdType="pmc">PMC7906686</ArticleId><ArticleId IdType="pubmed">33548184</ArticleId></ArticleIdList></Reference><Reference><Citation>Jalilian H., Amraei M., Javanshir E., Jamebozorgi K., Faraji-Khiavi F. Ethical considerations of the vaccine development process and vaccination: A scoping review. BMC Health Serv. Res. 2023;23:255. doi: 10.1186/s12913-023-09237-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-023-09237-6</ArticleId><ArticleId IdType="pmc">PMC10013982</ArticleId><ArticleId IdType="pubmed">36918888</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao K., Gillissie E.S., Lui L.M., Ceban F., Teopiz K.M., Gill H., Cao B., Ho R., Rosenblat J.D., McIntyre R.S. Immune response to vaccination in adults with mental disorders: A systematic review. J. Affect. Disord. 2022;304:66–77. doi: 10.1016/j.jad.2022.02.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2022.02.025</ArticleId><ArticleId IdType="pmc">PMC8837484</ArticleId><ArticleId IdType="pubmed">35167926</ArticleId></ArticleIdList></Reference><Reference><Citation>Surman O.S. Possible immunological effects of psychotropic medication. Psychosomatics. 1993;34:139–143. doi: 10.1016/S0033-3182(93)71904-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0033-3182(93)71904-0</ArticleId><ArticleId IdType="pubmed">8456156</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo R., Ciminale M., Ditommaso S., Siliquini R., Zotti C., Ruggenini A.M. Hepatitis B vaccination in psychiatric patients. Lancet. 1994;343:356. doi: 10.1016/S0140-6736(94)91193-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(94)91193-2</ArticleId><ArticleId IdType="pubmed">7905164</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller B.J., Culpepper N., Rapaport M.H. C-reactive protein levels in schizophrenia: A review and meta-analysis. Clin. Schizophr. Relat. Psychoses. 2014;7:223–230. doi: 10.3371/CSRP.MICU.020813.</Citation><ArticleIdList><ArticleId IdType="doi">10.3371/CSRP.MICU.020813</ArticleId><ArticleId IdType="pubmed">23428789</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical Features Patients Infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Fond G., Godin O., Boyer L., Berna F., Andrianarisoa M., Coulon N., Brunel L., Bulzacka E., Aouizerate B., Capdevielle D., et al. Chronic low-grade peripheral inflammation is associated with ultra resistant schizophrenia. Results from the FACE-SZ cohort. Eur. Arch. Psychiatry Clin. Neurosci. 2019;269:985–992. doi: 10.1007/s00406-018-0908-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00406-018-0908-0</ArticleId><ArticleId IdType="pubmed">29808267</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Knovich M.A., Coffman L.G., Torti F.M., Torti S.V. Serum ferritin: Past, present and future. Biochim. Biophys. Acta. 2010;1800:760–769. doi: 10.1016/j.bbagen.2010.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagen.2010.03.011</ArticleId><ArticleId IdType="pmc">PMC2893236</ArticleId><ArticleId IdType="pubmed">20304033</ArticleId></ArticleIdList></Reference><Reference><Citation>Taneri P.E., Gómez-Ochoa S.A., Llanaj E., Raguindin P.F., Rojas L.Z., Roa-Díaz Z.M., Salvador D., Jr., Groothof D., Minder B., Kopp-Heim D., et al. Anemia and iron metabolism in COVID-19: A systematic review and meta-analysis. Eur. J. Epidemiol. 2020;35:763–773. doi: 10.1007/s10654-020-00678-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-020-00678-5</ArticleId><ArticleId IdType="pmc">PMC7438401</ArticleId><ArticleId IdType="pubmed">32816244</ArticleId></ArticleIdList></Reference><Reference><Citation>Carubbi F., Salvati L., Alunno A., Maggi F., Borghi E., Mariani R., Mai F., Paoloni M., Ferri C., Desideri G., et al. Ferritin is associated with the severity of lung involvement but not with worse prognosis in patients with COVID-19: Data from two Italian COVID-19 units. Sci. Rep. 2021;11:4863. doi: 10.1038/s41598-021-83831-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-83831-8</ArticleId><ArticleId IdType="pmc">PMC7921386</ArticleId><ArticleId IdType="pubmed">33649408</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubey S., Biswas P., Ghosh R., Chatterjee S., Dubey M.J., Chatterjee S., Lahiri D., Lavie C.J. Psychosocial impact of COVID-19. Diabetes Metab. Syndr. Clin. Res. Rev. 2020;14:779–788. doi: 10.1016/j.dsx.2020.05.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.05.035</ArticleId><ArticleId IdType="pmc">PMC7255207</ArticleId><ArticleId IdType="pubmed">32526627</ArticleId></ArticleIdList></Reference><Reference><Citation>Vindegaard N., Benros M.E. COVID-19 pandemic and mental health consequences: Systematic review of the current evidence. Brain Behav. Immun. 2020;89:531–542. doi: 10.1016/j.bbi.2020.05.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.05.048</ArticleId><ArticleId IdType="pmc">PMC7260522</ArticleId><ArticleId IdType="pubmed">32485289</ArticleId></ArticleIdList></Reference><Reference><Citation>Graña C., Ghosn L., Evrenoglou T., Jarde A., Minozzi S., Bergman H., Buckley B.S., Probyn K., Villanueva G., Henschke N., et al. Efficacy and Safety of COVID-19 Vaccines. Cochrane Database Syst. Rev. 2022;12:CD015477. doi: 10.1002/14651858.cd015477.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.cd015477</ArticleId><ArticleId IdType="pmc">PMC9726273</ArticleId><ArticleId IdType="pubmed">36473651</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez Bernal J., Andrews N., Gower C., Gallagher E., Simmons R., Thelwall S., Stowe J., Tessier E., Groves N., Dabrera G., et al. Effectiveness of COVID-19 Vaccines against the B.1.617.2 (Delta) Variant. N. Engl. J. Med. 2021;385:585–594. doi: 10.1056/NEJMoa2108891.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2108891</ArticleId><ArticleId IdType="pmc">PMC8314739</ArticleId><ArticleId IdType="pubmed">34289274</ArticleId></ArticleIdList></Reference><Reference><Citation>Lakbar I., Luque-Paz D., Mege J.-L., Einav S., Leone M. COVID-19 Gender Susceptibility and Outcomes: A Systematic Review. PLoS ONE. 2020;15:e0241827. doi: 10.1371/journal.pone.0241827.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0241827</ArticleId><ArticleId IdType="pmc">PMC7608911</ArticleId><ArticleId IdType="pubmed">33141872</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel R., Kooner J.S., Zhang W. Comorbidities Associated with the Severity of COVID-19, and Differences across Ethnic Groups: A UK Biobank Cohort Study. BMC Public Health. 2023;23:1566. doi: 10.1186/s12889-023-16499-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-023-16499-6</ArticleId><ArticleId IdType="pmc">PMC10436456</ArticleId><ArticleId IdType="pubmed">37592225</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z.-H., Tang Y., Cheng Q. Diabetes Increases the Mortality of Patients with COVID-19: A Meta-Analysis. Acta Diabetol. 2021;58:139–144. doi: 10.1007/s00592-020-01546-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00592-020-01546-0</ArticleId><ArticleId IdType="pmc">PMC7311595</ArticleId><ArticleId IdType="pubmed">32583078</ArticleId></ArticleIdList></Reference><Reference><Citation>Iloanusi S., Mgbere O., Essien E.J. Polypharmacy among COVID-19 Patients: A Systematic Review. J. Am. Pharm. Assoc. 2021;61:e14–e25. doi: 10.1016/j.japh.2021.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.japh.2021.05.006</ArticleId><ArticleId IdType="pmc">PMC8149164</ArticleId><ArticleId IdType="pubmed">34120855</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P., McAuley D.F., Brown M., Sanchez E., Tattersall R.S., Manson J.J., HLH Across Speciality Collaboration, UK COVID-19: Consider Cytokine Storm Syndromes and Immunosuppression. Lancet. 2020;395:1033–1034. doi: 10.1016/S0140-6736(20)30628-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30628-0</ArticleId><ArticleId IdType="pmc">PMC7270045</ArticleId><ArticleId IdType="pubmed">32192578</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., Xiang J., Wang Y., Song B., Gu X., et al. Clinical Course and Risk Factors for Mortality of Adult Inpatients with COVID-19 in Wuhan, China: A Retrospective Cohort Study. Lancet. 2020;395:1054–1062. doi: 10.1016/S0140-6736(20)30566-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozkurt F.T., Tercan M., Patmano G., Bingol Tanrıverdi T., Demir H.A., Yurekli U.F. Can Ferritin Levels Predict the Severity of Illness in Patients with COVID-19? Cureus. 2021;13:e12832. doi: 10.7759/cureus.12832.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.12832</ArticleId><ArticleId IdType="pmc">PMC7899245</ArticleId><ArticleId IdType="pubmed">33633875</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardoso T.d.A., Silva R.H., Fernandes J.L., Arent C.O., Amboni G., Borba L.A., Padilha A.P.Z., Botelho M.E.M., Maciel A.L., Barichello T., et al. Stress Levels, Psychological Symptoms, and C-Reactive Protein Levels in COVID-19: A Cross-Sectional Study. J. Affect. Disord. 2023;330:216–226. doi: 10.1016/j.jad.2023.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2023.03.019</ArticleId><ArticleId IdType="pmc">PMC10005840</ArticleId><ArticleId IdType="pubmed">36907459</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuna Ö., Ermis C., Darcin A.E., Dagistan E., Salman S. Comparison of Inflammation Markers and Severity of Illness among Patients with COVID-19, Acute Psychiatric Disorders and Comorbidity. Eur. J. Psychiatry. 2023;37:125–132. doi: 10.1016/j.ejpsy.2022.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejpsy.2022.01.008</ArticleId><ArticleId IdType="pmc">PMC8806143</ArticleId><ArticleId IdType="pubmed">35125586</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C., Chen X., Cai Y., Xia J., Zhou X., Xu S., Huang H., Zhang L., Zhou X., Du C., et al. Risk Factors Associated with Acute Respiratory Distress Syndrome and Death in Patients with Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern. Med. 2020;180:934–943. doi: 10.1001/jamainternmed.2020.0994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2020.0994</ArticleId><ArticleId IdType="pmc">PMC7070509</ArticleId><ArticleId IdType="pubmed">32167524</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>